Schwartz GK - Search Results

1

Inhibition of NF-κB-Dependent Signaling Enhances Sensitivity and Overcomes Resistance to BET Inhibition in Uveal Melanoma.

Ambrosini G, Do C, Tycko B, Realubit RB, Karan C, Musi E, Carvajal RD, Chua V, Aplin AE, Schwartz GK. Ambrosini G, et al. Among authors: schwartz gk. Cancer Res. 2019 May 1;79(9):2415-2425. doi: 10.1158/0008-5472.CAN-18-3177. Epub 2019 Mar 18. Cancer Res. 2019. PMID: 30885979 Free PMC article.

2

Characterization of cell lines established from human gastric-esophageal adenocarcinomas. Biologic phenotype and invasion potential.

Altorki N, Schwartz GK, Blundell M, Davis BM, Kelsen DP, Albino AP. Altorki N, et al. Among authors: schwartz gk. Cancer. 1993 Aug 1;72(3):649-57. doi: 10.1002/1097-0142(19930801)72:3<649::aid-cncr2820720305>3.0.co;2-l. Cancer. 1993. PMID: 8334620

3

Drg1, a novel target for modulating sensitivity to CPT-11 in colon cancer cells.

Motwani M, Sirotnak FM, She Y, Commes T, Schwartz GK. Motwani M, et al. Among authors: schwartz gk. Cancer Res. 2002 Jul 15;62(14):3950-5. Cancer Res. 2002. PMID: 12124325

4

Flavopiridol targets c-KIT transcription and induces apoptosis in gastrointestinal stromal tumor cells.

Sambol EB, Ambrosini G, Geha RC, Kennealey PT, Decarolis P, O'connor R, Wu YV, Motwani M, Chen JH, Schwartz GK, Singer S. Sambol EB, et al. Among authors: schwartz gk. Cancer Res. 2006 Jun 1;66(11):5858-66. doi: 10.1158/0008-5472.CAN-05-2933. Cancer Res. 2006. PMID: 16740725

5

Aurora kinases: new targets for cancer therapy.

Carvajal RD, Tse A, Schwartz GK. Carvajal RD, et al. Among authors: schwartz gk. Clin Cancer Res. 2006 Dec 1;12(23):6869-75. doi: 10.1158/1078-0432.CCR-06-1405. Clin Cancer Res. 2006. PMID: 17145803 Review.

6

Mouse double minute antagonist Nutlin-3a enhances chemotherapy-induced apoptosis in cancer cells with mutant p53 by activating E2F1.

Ambrosini G, Sambol EB, Carvajal D, Vassilev LT, Singer S, Schwartz GK. Ambrosini G, et al. Among authors: schwartz gk. Oncogene. 2007 May 24;26(24):3473-81. doi: 10.1038/sj.onc.1210136. Epub 2006 Dec 4. Oncogene. 2007. PMID: 17146434

7

Targeting checkpoint kinase 1 in cancer therapeutics.

Tse AN, Carvajal R, Schwartz GK. Tse AN, et al. Among authors: schwartz gk. Clin Cancer Res. 2007 Apr 1;13(7):1955-60. doi: 10.1158/1078-0432.CCR-06-2793. Clin Cancer Res. 2007. PMID: 17404075 Review.

8

Gene expression profiling of liposarcoma identifies distinct biological types/subtypes and potential therapeutic targets in well-differentiated and dedifferentiated liposarcoma.

Singer S, Socci ND, Ambrosini G, Sambol E, Decarolis P, Wu Y, O'Connor R, Maki R, Viale A, Sander C, Schwartz GK, Antonescu CR. Singer S, et al. Among authors: schwartz gk. Cancer Res. 2007 Jul 15;67(14):6626-36. doi: 10.1158/0008-5472.CAN-07-0584. Cancer Res. 2007. PMID: 17638873

9

The cyclin-dependent kinase inhibitor flavopiridol potentiates the effects of topoisomerase I poisons by suppressing Rad51 expression in a p53-dependent manner.

Ambrosini G, Seelman SL, Qin LX, Schwartz GK. Ambrosini G, et al. Among authors: schwartz gk. Cancer Res. 2008 Apr 1;68(7):2312-20. doi: 10.1158/0008-5472.CAN-07-2395. Cancer Res. 2008. PMID: 18381438

10

Sorafenib inhibits growth and mitogen-activated protein kinase signaling in malignant peripheral nerve sheath cells.

Ambrosini G, Cheema HS, Seelman S, Teed A, Sambol EB, Singer S, Schwartz GK. Ambrosini G, et al. Among authors: schwartz gk. Mol Cancer Ther. 2008 Apr;7(4):890-6. doi: 10.1158/1535-7163.MCT-07-0518. Mol Cancer Ther. 2008. PMID: 18413802 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

302 results

Search Page

Filters